Revolution Medicines, Inc. is 3.7x more valuable than BIO-TECHNE Corp by market capitalization ($30.65 B vs $8.22 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | TECH | RVMD |
|---|---|---|
| Market cap | $8.22 B | $30.65 B |
| US-listed rank | #1055 | #454 |
| Revenue (latest FY) | $1.22B | $0.00 |
| Net income (latest FY) | $73.40M | -$1.13B |
| Net margin | 6.0% | - |
| P/E (trailing FY) | 112.0 | - |
| SEC filings | 1,229 | 782 |
Revolution Medicines, Inc. is 3.7x more valuable than BIO-TECHNE Corp by market capitalization ($30.65 B vs $8.22 B).
In their latest fiscal years, BIO-TECHNE Corp reported $1.22B in revenue while Revolution Medicines, Inc. reported $0.00.
Full pages: BIO-TECHNE Corp and Revolution Medicines, Inc., or browse the full rankings.